Isotechnika Pharma Inc IPHAF

good news...but for who?

[teevee]

The good news is that Paladin gets to monetize its shares in ISA and keep the royalty in voclosporin and any new drug ever developed by ISA.....The good news for the Koreans is they get to effectively take over the company by buying stock with private placements. The good news for ISA management and insiders is the pay checks keep coming and they have effectively got out from under a bad situation by doing a deal that results in a change in control, and eventually a change in corporate offices and laboratory to Korea.
The bad news for ISA shareholders is that past Korean company involvement in Canadian junior equities indicates ISA will be further diluted and then the stock will be rolled back, followed by more placements. 
Paladin is monetizing now for good reasons.